Cerebrospinal fluid pterins and folates in Aicardi-Goutieres syndrome: a new phenotype
Détails
ID Serval
serval:BIB_5A343DC2A525
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Cerebrospinal fluid pterins and folates in Aicardi-Goutieres syndrome: a new phenotype
Périodique
Neurology
ISSN
1526-632X
Statut éditorial
Publié
Date de publication
09/2003
Peer-reviewed
Oui
Volume
61
Numéro
5
Pages
642-7
Notes
Case Reports
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Sep 9
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Sep 9
Résumé
OBJECTIVE: To describe three unrelated children with a distinctive variant of Aicardi-Goutieres syndrome (AGS) characterized by microcephaly, severe mental and motor retardation, dyskinesia or spasticity, and occasional seizures. RESULTS: Neuroimaging showed bilateral calcification of basal ganglia and white matter. CSF glucose, protein, cell count, and interferon alpha were normal. Abnormal CSF findings included extremely high neopterin (293 to 814 nmol/L; normal 12 to 30 nmol/L) and biopterin (226 to 416 nmol/L; normal 15 to 40 nmol/L) combined with lowered 5-methyltetrahydrofolate (23 to 48 nmol/L; normal 64 to 182 nmol/L) concentrations in two patients. The absence of pleocytosis and normal CSF interferon alpha was a characteristic finding compared to the classic AGS syndrome. Genetic and enzymatic tests excluded disorders of tetrahydrobiopterin metabolism, including mutation analysis of GTP cyclohydrolase feed-back regulatory protein. CSF investigations in three patients with classic AGS also showed increased pterins and partially lowered folate levels. CONCLUSIONS: Intrathecal overproduction of pterins is the first biochemical abnormality identified in patients with AGS variants. Long-term substitution with folinic acid (2-4 mg/kg/day) resulted in substantial clinical recovery with normalization of CSF folates and pterins in one patient and clinical improvement in another. The underlying defect remains unknown.
Mots-clé
Basal Ganglia/pathology
Brain Diseases/*cerebrospinal fluid/diagnosis/enzymology
DNA Mutational Analysis
Decalcification, Pathologic/diagnosis
Dyskinesias/diagnosis
Female
Fibroblasts/enzymology
Folic Acid/*cerebrospinal fluid
Humans
Infant
Infant, Newborn
Intracellular Signaling Peptides and Proteins
Leucovorin/therapeutic use
Male
Mental Retardation/diagnosis
Microcephaly/diagnosis
Muscle Hypertonia/diagnosis
Phenotype
Proteins/genetics
Psychomotor Disorders/diagnosis
Pterins/*cerebrospinal fluid/metabolism
Seizures/diagnosis
Syndrome
Tomography, X-Ray Computed
Pubmed
Web of science
Création de la notice
21/01/2008 12:50
Dernière modification de la notice
20/08/2019 14:13